Cytogenetic damage in peripheral lymphocytes of mitochondrial disease patients A. NaccaratiS. MolinuL. Migliore Pages: S963 - S965
Regenerative capacity of human satellite cells: the mitotic clock in cell transplantation S. Di DonnaV. RenaultV. Mouly Pages: S943 - S951
Quantitative myotonia assessment: an experimental protocol V. SansoneK. MarinouG. Meola Pages: S971 - S974
Potential involvement of ubiquinone in myotonic dystrophy pathophysiology: new diagnostic approaches for new rationale therapeutics D. TedeschiV. LombardiL. Murri Pages: S979 - S980
A novel mtDNA mutation in the ATPase6 gene studied by E. coli modeling R. CarrozzoJ. MurrayF.M. Santorelli Pages: S983 - S984
Retroviral vectors for gene therapy of Duchenne muscular dystrophy A. FassatiN. Bresolin Pages: S925 - S927
Gene transfer in skeletal muscle by systemic injection of DODAC lipopolyplexes F. PampinellaM. PozzobonI. Vitiello Pages: S967 - S969
Correlation of clinical function and muscle CT scan images in limb-girdle muscular dystrophy M. VlakE. van der KooiC. Angelini Pages: S975 - S977
Long-term treatment with idebenone and riboflavin in a patient with MELAS A. NapolitanoS. SalvettiC. Giraldi Pages: S981 - S981
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies G. SicilianoM. MancusoA. Iudice Pages: S985 - S987
Molecular basis for treatment of mitochondrial myopathies R.W. TaylorT.M. WardellD.M. Turnbull Pages: S909 - S912
Mitochondrial encephalomyopathies: therapeutic approaches S. DiMauroM. HiranoE.A. Schon Pages: S901 - S908
